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Melanoma inhibitory activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP) is a small soluble protein secreted
from chondrocytes. It was identiﬁed as the prototype of a family of extracellular proteins adopting an SH3 domain-like fold. In
order to study the consequences of MIA/CD-RAP deﬁciency in detail we used mice with a targeted gene disruption of MIA/CD-
RAP (MIA / ) and analyzed cartilage organisation and differentiation in in vivo and in vitro models. Cartilage formation and
regeneration was determined in models for osteoarthritis and fracture healing in vivo, in addition to in vitro studies using
mesenchymal stem cells of MIA /  mice. Interestingly, our data suggest enhanced chondrocytic regeneration in the MIA / 
mice, modulated by enhanced proliferation and delayed differentiation. Expression analysis of cartilage tissue derived from
MIA / micerevealedstrongdownregulationofnuclearRNA-bindingprotein 54-kDa(p54
nrb),arecentlydescribedmodulatorof
Sox9activity.Inthisstudy,wepresentp54
nrbasamediatorofMIA/CD-RAPtopromotechondrogenesis.Takentogether,ourdata
indicate that MIA/CD-RAP is required for differentiation in cartilage potentially by regulating signaling processes during
differentiation.
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Melanoma inhibitory activity/cartilage-derived retinoic
acid-sensitive protein (MIA/CD-RAP) was cloned as a
secreted protein from human melanoma cell lines
1,2 and
independently identiﬁed by differential display comparing
differentiated with dedifferentiated chondrocytes.
3 Several
studies indicate an important role of MIA/CD-RAP in tumor
progression and metastasis of malignant melanoma by
mediatingcelldetachmentfromextracellularmatrixmolecules
such as ﬁbronectin.
4
In situ hybridization of mouse embryos revealed MIA/CD-
RAP expression starting from the beginning of chondrogen-
esis and abundant throughout cartilage development.
3,5
Moreover, MIA/CD-RAP was revealed to be a speciﬁc marker
for chondrocytic differentiation.
6
Cartilage damage due to rheumatoid arthritis or mechanical
overload,forinstanceduringmarathonrunning,releasesMIA/
CD-RAP from the chondroid matrix and can be monitored
clinically by enhanced MIA/CD-RAP serum levels.
7,8 Based
onitshighlyrestrictedactivity,theMIA/CD-RAPpromoterwas
used to study transcriptional mechanisms mediating chondro-
cyte differentiation. Expression of a LacZ-reporter gene
under control of the 2251bp MIA/CD-RAP promoter was
exclusively observed in cartilage.
9 These data suggested that
MIA/CD-RAP may be functionally important for cartilage
differentiation and for speciﬁc morphogenetic events during
embryogenesis.
To study the consequences of MIA/CD-RAP deﬁciency
in vivo we generated MIA/CD-RAP-deﬁcient (MIA / )
mice.
10 First data gained from the analysis of the MIA / 
mice indicate that MIA/CD-RAP function is required for the
highly ordered ﬁbrillar ultra structure of cartilage. Electron-
microscopic analyses reveal defects in collagen ﬁber density,
diameter and arrangement as well as changes in the number
and morphology of chondrocytic microvilli.
10
In a recent study, we could show that MIA/CD-RAP can
inﬂuence cartilage differentiation.
11 MIA/CD-RAP was not
able to induce chondrocytic differentiation of human me-
senchymal stem cells on its own but induced differentiation
mediated by transforming growth factor (TGF)-b3 and
reverted osteogenic differentiation by BMP2 into more
chondrogenic differentiation. Therefore, we aimed to analyse
the molecular function of MIA/CD-RAP in cartilage differentia-
tion using in vivo models for cartilage destruction and
regeneration and in vitro models using mesenchymal stem
cells of MIA /  mice.
Results
In an initial study, we analyzed spontaneous emerging
osteoarthritis (OA) in 2-years old mice and surprisingly
revealed reduced OA in MIA /  mice compared with WT
(data not shown). We, therefore, aimed to analyze this ﬁnding
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differentiation to reveal whether MIA is important for cartilage
repair or cartilage resistance.
Models for osteoarthritis and fracture healing revealed
enhanced cartilage repair in MIA /  mice. To determine
the effects of MIA/CD-RAP on cartilage under pathological
situations we used MIA/CD-RAP-deﬁcient mice in in vivo
models for osteoarthritis and fracture healing. In both models
cartilage degradation, regeneration and differentiation can be
evaluated.
OAwasinducedin6-weekoldmicebydetachingthemedial
meniscotibial ligament from the tibia plateau and progression
of OA was analyzed in mice knee joints after 10, 21 and 42
days. Interestingly, OA development scored by grade and
stage was markedly reduced in MIA /  mice compared with
wild-type (WT) mice after 21 and 42 days (Figure 1a).
Nevertheless, MIA /  mice developed OA at all, which rose
at day 21, but was remarkably reduced till day 42 pointing
towardscartilageregeneration.Carefulanalysesofthemedial
part of knee joints in 42-days OA mice by hematoxylin and
eosin (HE) staining revealed strong cartilage damage in WT
mice in contrast to MIA /  mice (Figure 1b). Surprisingly,
proliferating chondrocytes, illustrated by PCNA staining in the
knee joints of mice 10 days after OA was induced, were
observed in MIA /  mice but not in WT (Figure 1c). To
analyse cartilage formation in MIA /  mice in detail, we used
the fracture model to observe de novo cartilage and bone
formation in the callus. Bone formation was normal or even
slightly reduced (Figure 1d). Interestingly, cartilage formation
was signiﬁcantly elevated in MIA /  mice at day 7 after
fracture. At day 9 and 11 the overall percentage of cartilage
0
1
2
3
4
5
6
7
8
9
10
11
control OA
21d 42d
*
**
WT
MIA-/-
ns ns ns
21d 42d 10d 10d
S
c
o
r
e
 
[
G
r
a
d
e
+
S
t
a
g
e
]
a
WT MIA-/-
0.0
0.5
1.0
1.5
2.0
2.5
*
no pos.
cells
P
C
N
A
 
p
o
s
.
 
c
e
l
l
s
/
1
0
H
P
F
c MIA-/- WT
OA 10d
(PCNA)
20μm 20μm
20μm 20μm
b
MIA-/- WT
control
(42d)
OA
(42d)
100μm
100μm 100μm
100μm
d cartilage day
40
50
60
WT
MIA-/-
%
 
c
a
r
t
i
l
a
g
e
bone day
4 5 6 7 8 9 10 11 12
0.0
2.5
5.0
7.5
10.0
12.5
15.0
17.5
20.0
22.5
WT
MIA-/-
days
%
 
b
o
n
e
4 5 6 7 8 9 10 11 12
0
10
20
30
*
days
e collagen type II collagen type X PCNA
WT
MIA-/-
100μm 50μm
50μm
50μm
50μm
100μm
100μm
100μm
50μm
50μm
50μm
100μm
100μm
100μm
50μm
50μm
50μm
100μm
100μm
100μm
50μm 100μm 50μm 100μm
Figure 1 (a–c) Osteoarthritis(OA) was reducedin MIA /  mice, mediated by enhancedproliferation. Anexperimentalosteoarthritismodel was used,in whichinstability
to knee joints was created by detaching the medial meniscotibial ligament from the tibia plateau of 6-week old WT and MIA /  mice. (a) After 10, 21 and 42 days OA
development was scored by grade and stage. OA was markedly reduced in MIA /  mice. We observed enhanced cartilage regeneration at day 42 in MIA /  mice. The
score of 10-days old control mice was zero. The data are represented as means±S.D. (b) HE staining of the medial part of knee joints 42 days after inducing osteoarthritis.
Arrows indicate cartilage destruction. (c) PCNA immunhistological staining of knee joints, 10 days after OA was induced, showed PCNA positive chondrocytes in MIA / 
mice.ArrowsindicatePCNA-positivecells.PCNA-positivecellsinthekneejointswerequantiﬁed.NoPCNA-positivecellswerefoundinWTmice.Thedataarerepresentedas
means±S.D. (d and e) Fracture healing model revealed enhanced cartilage formation. Tibia of 6–8-weeks old mice were broken and cartilage-/bone formation in the callus
was analyzed after 5, 7, 9 and 11 days. (d) Cartilage formation was increased in MIA /  mice compared with WT, whereas bone formation showed no difference. The data
are representedas means±S.D.(e)CollagentypeII, XandPCNAstainingofserial sectionsof thecallus7 daysafterthefracture.PCNAstainingrevealedmoreproliferating
collagen type II-positive cells in MIA /  mice compared with control. Arrows present PCNA-positive cells. Small baskets indicate the augmented area, which displays the
same detail of the respective serial section. (ns, not signiﬁcant; *Po0.05; **Po0.01)
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2
Cell Death and Diseasedid not differ between WT and MIA / . To further evaluate
cartilage differentiation and proliferation at day 7 after
fracture, sections were stained with anti-collagen type II, type
X and PCNA antibodies showing that the amount of
proliferating collagen type II-positive undifferentiated chon-
drocytes was signiﬁcantly enhanced in MIA /  mice
(Figure 1e). Hence, raised cartilage formation in MIA / 
was due to enhanced proliferation at early time points of
fracture healing.
Accelerated proliferation and delayed differentiation in
MIA /  murine mesenchymal stem cells (mMSC). As
these models suggest accelerated proliferation of early
chondrocytes before differentiation, we examined the effect
of loss of MIA/CD-RAP on proliferation of primary mMSC
derived from WT and MIA /  littermates. Dynamic cell-cycle
kinetic was analyzed in vitro through continued 5-bromo-2-
deoxyuridine (BrdU) incubation using the ﬂow cytometric
BrdU/Hoechst quenching method in which up to three
consecutive cell cycles can be investigated.
The effect of MIA/CD-RAP deﬁciency on cell-cycle progres-
sion in murine mesenchymal stem cells stained with Hoechst
33258 (Figure 2a, abscissa) and with Propidium iodide (PI)
(Figure2a,ordinate)isshowninFigure2aaftertreatmentwith
BrdU.After96hofBrdUincubation,moremMSCderivedfrom
MIA /  mice had entered the ﬁrst (42%) and second cell
cycle (38%) compared with WT (ﬁrst: 15%, second: 18%)
(Figure 2b). A higher number of cells (66%) from WT
littermates did not proliferate and represented G0/G1 cells
of the ﬁrst cell cycle than MIA/CD-RAP-deﬁcient cells (20%).
Comparing cell cycle distribution of proliferating cells between
WT and MIA /  mMSC, more MIA /  stem cells were
located in respective stages as WT (Figure 2b). In summary,
cell-cycle progression was enhanced by loss of MIA/CD-RAP
in murine mesenchymal stem cells.
RNA-array analysis of murine chondrocytes derived from
MIA /  and WT littermates revealed upregulation of Cyclin
D2 in MIA /  chondrocytes (unpublished data). Cyclin D2
(CCND2) gene is a member of type-D cyclin family, which
binds to and activates cyclin-dependent kinase (CDK) 4/6.
12
Activated CCND2-CDK4/6 complex phosphorylates down-
streamproteins, which are essential forcell-cycle progression
from G1- to S-phase. Cyclin D2 is therefore an important
initiator of proliferation.
13
We determined differential Cyclin D2 mRNA expression by
quantitative real-time PCR (qRT-PCR) and protein levels per
western blot in chondrocyte progenitor cells. Murine me-
senchymal stem cells from MIA /  littermates were com-
pared with WT. In-line with the gene-array analysis, the
relative CCND2 mRNA and protein expression was signiﬁ-
cantly higher in MIA /  MSC (Figure 2c I). Thus loss of MIA/
CD-RAP resulted in increased CCND2 expression, which
promotes enhanced proliferation.
To conﬁrm these results we used siRNA against MIA/CD-
RAP in WT mMSC and re-expressed human MIA (hMIA) in
MIA /  mMSC, respectively. The efﬁciency of knocking
down MIA/CD-RAP was shown by qRT-PCR (Figure 2d). As
anticipated, MIA/CD-RAP knockdown in WT cells resulted in
overexpression of Cyclind D2 on mRNA and protein level
(Figure 2c II). Re-expression of hMIA in MIA /  mMSC led to
a signiﬁcant decrease in Cyclin D2 mRNA expression (Figure
2c III).
In order to examine the effect of MIA /  on proliferation
under chondrogenic conditions, proliferation of mesenchymal
stemcellsderivedfromWTandMIA / micewasanalyzedin
monolayer cultures by XTT assay over 8 days. Chondrogenic
differentiation was induced by TGF-b3. TGF-b3 is implicated
in the process of endochondral ossiﬁcation, which is initiated
by the inhibition of proliferation of mesenchymal stem cells
anddifferentiationintochondrocytes.
14It,therefore,initiates a
decline in proliferation of mesenchymal cells and promotes
differentiation. In WT mMSC, relative proliferation was
signiﬁcantly reduced through treatment with TGF-b3 com-
pared with MIA /  mMSC where relative proliferation
remained unchanged (Figure 2e I). Consistent with these
results, re-expression of hMIA in MIA /  cells re-established
the WT phenotype (Figure 2e II). MIA/CD-RAP mRNA
knockdown by siRNA in WT cells led to no alteration in
proliferation after induction compared with control (Figure 2e
III). These data suggest prolonged proliferation and possibly
delayed differentiation because of lack of MIA/CD-RAP in
chondrogenic conditions.
To show the impact of MIA/CD-RAP on cartilage differ-
entiation on transcriptional level, transcriptional activation of
the Col2a1 promoter, an early marker for cartilage differentia-
tion,
15 was analyzed in mMSC originated from WT and
MIA / miceusingareportergeneassay.Differentiationwas
induced by TGF-b3. There was signiﬁcant less activation of
the Col2a1 promoter in MIA /  compared with WT (Figure 2f
I), and in WT cells in which MIA/CD-RAP was knocked down
(Figure 2f II) suggesting that MIA/CD-RAP is an important
factor for initiation of Col2a1 expression and differentiation.
Nuclear RNA-binding protein 54-kDa (p54
nrb)i s
downregulated in cartilage of MIA /  mice. In a study
to identify MIA/CD-RAP regulated genes in malignant
melanoma, a Powerblot analysis of MIA /  cell clones of
the melanoma cell line Hmb2
16 was performed. P54
nrb was
found to be a MIA/CD-RAP-regulated gene (Figure 3a).
Alerted by a recent study presenting an important role of
p54
nrb in enhancing Sox9-mediated transcription of
Col2a1,
17 we concentrated on this MIA/CD-RAP target gene.
Expression analysis of p54
nrb mRNA levels in cartilage of
ear and sternum of adult mice (Figure 3b), as well as on
protein levels in rips of 15.5-days old mouse embryos, using
p54
nrb-speciﬁc antibodies in immunohistochemistry
(Figure 3c), revealed strong downregulation of p54
nrb in
MIA /  mice. Next, we analyzed expression of p54
nrb during
redifferentiation of dedifferentiated chondrocytes in three-
dimensional (3D) pellet cultures. We revealed strong induc-
tion of expression in WT chondrocytes, whereas p54
nrb
expression in MIA /  cells was markedly reduced
(Figure 3d).
P54
nrb is a mediator of MIA/CD-RAP in chondrogenesis.
. To conﬁrm the functional role of MIA/CD-RAP and its
downstream target p54
nrb on differentiation and
proliferation, siRNA technology against p54
nrb was used.
The efﬁciency of knocking down p54
nrb was shown by
qRT-PCR and western blot analysis (Figure 4a).
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Cell Death and DiseaseAnalysis of cartilage differentiation on transcriptional level
measured by the activity of the Col2a1 promoter and Col2
mRNA levels showed a signiﬁcant reduction in WT cells
transfected with p54
nrb siRNA compared with control (Figure
4b I and II). Interestingly, this result corresponded to the
effects in MIA /  MSC and in WT mMSC treated with siRNA
against MIA/CD-RAP (Figure 2f). Col2a1 promoter activity
and Col2 mRNA expression in MIA /  MSC treated with
siRNA against sip54
nrb revealed no signiﬁcant reduction of
Col2a1 promoter activity as well as mRNA expression (Figure
4b III and IV). To conﬁrm the regulation of Col2a1 by MIA/CD-
RAP and p54
nrb we simultaneously reexpressed hMIA and
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Figure2 ProliferationwasenhancedinMIA / mMSC.(a)Modiﬁcationofcellcycledistributionofmurinemesenchymalstemcells(mMSC)byMIA/CD-RAPusingBrdU/
Hoechstquenchingmeasurement.BrdU-quenchedHoechst33258versusPIﬂuorescencedensityplotsofcellsafter96hBrdUtreatment.Cellsoftheﬁrstcellcyclearelabeled
G0/G1, S, and G2. Those of the second cycle are marked G10,S 0 and G20.( b) Distribution of mMSC cells in cell cycle compartments. WT cells showed a delay in cell-cycle
progression compared with MIA /  cells represented by a high G0/G1 value of WT (66%) compared with MIA /  (20%). In contrast to MIA /  mMSC (80%) only 33% of
all WT cells entered the ﬁrst or second cell cycle after 96h of incubation. The data are represented as means±S.D. (c) Comparison of the expression of Cyclin D2 using
quantitative real-time PCR and western blot analysis in mMSC. Cyclin D2 expression was signiﬁcantly increased in MIA /  mMSC on mRNA and protein level (I). In each
case two different isolations of untreated mMSC are shown in the western blot. WT mMSC transfected with siRNA speciﬁc for MIA/CD-RAP showed signiﬁcant increase in
Cyclin D2 expression (II). Re-expression of hMIA in MIA /  mMSC led to signiﬁcant decrease in Cyclin D2 mRNA expression (III). The data are represented as
means±S.D., after normalization to WT mMSC or control. (d) Messenger RNA-expression analysis by qRT-PCR of murine mesenchymal stem cells transfected with siRNA
speciﬁc for MIA/CD-RAP. MIA/CD-RAP was successfully downregulated compared with si control transfected cells. The data are represented as means±S.D., after
normalization to the control siRNA. (e) Relative proliferation for 8 days compared between WT and MIA /  mesenchymal stem cells using XTT assay. Differentiation was
induced by TGF-b3. Induction of differentiation led to reduction of proliferation in WT cells (I), however, proliferation in MIA /  cells as well as in siMIA-transfected cells
stayedunchanged (III). MIA / cellsinwhichhMIAwas re-inducedshowedimpairedproliferation afterinductionof differentiation withTGF-b3(II). Thedataarerepresented
as means±S.D., after normalization to untreated cells. Differentiation was diminished due to MIA/CD-RAP loss. (f) Col2 promoter activity, analyzed by reporter gene assay,
was signiﬁcantly decreased in MIA /  mMSC (I) and in WT cells transfected with MIA/CD-RAP siRNA (II). Differentiation was induced by TGF-b3. Data are represented as
means±S.D., after normalization to pGL2basic transfected cells. (ns, not signiﬁcant; *Po0.05; **Po0.01; ***Po0.001)
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Cell Death and Diseasedecreased p54
nrb levels by siRNA technology in MIA / 
MSC. As expected, reexpression of MIA/CD-RAP led to an
increase in Col2a1 promoter activity, whereas simultaneous
knock down of p54
nrb signiﬁcantly diminished Col2a1 promo-
teractivity(Figure4bV).Therewasnosigniﬁcantdifferencein
Col2a1 promoter activity in dependency on p54
nrb in cells
transfected with the control plasmid pCMX-PL1. Conse-
quently,we couldconﬁrm thatMIA/CD-RAP regulated Col2a1
expression through p54
nrb.
Overexpression of human p54
nrb (hp54
nrb) in MIA / 
MSCsresultedinsigniﬁcantreductionofCyclinD2expression
(Figure 4c I) and knockdown of p54
nrb in MSC WT led to
increased Cyclin D2 expression (Figure 4c II). In agreement
with the data presented in Figure 2e II and III, MIA /  cells
transfected with hp54
nrb showed reduced proliferation under
treatment with TGF-b3 (Figure 4d I), whereas WT cells in
which p54
nrb expression was silenced showed no changes
in relative proliferation under differentiating conditions (Figure
4d II). These data showed that MIA/CD-RAP and p54
nrb have
the same inﬂuence on proliferation and differentiation.
Reexpression of hMIA and simultaneous knockdown of
p54
nrb mRNA expression in MIA /  mMSC resulted in no
modiﬁcation of proliferation despite induction of differentiation
byTGF-b3 (Figure 4dIII).P54
nrbturned out tobethe mediator
of MIA/CD-RAP in promoting chondrogenesis by initiating
inhibition of proliferation and inducing differentiation.
P54
nrb is not regulated by ERK signalling. It is known that
MIA/CD-RAP can inhibit ERK activity through negative
regulation of integrin alpha 5 activity.
18 In a recent
study, inhibition of ERK signaling by MIA/CD-RAP could
be conﬁrmed in chondrocytes through binding to integrin
alpha 5.
11
Therefore, the role of ERK signaling on the regulation of
p54
nrb expression was analyzed. The ERK signalling pathway
was speciﬁcally inhibited using the MEK1/2 inhibitors
PD98059 and UO126 in WT MSC. The results revealed no
regulation of p54
nrb expression, neither on mRNA nor on
protein level (Figure 5a).
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Figure 3 Strong downregulation of p54
nrb in MIA /  specimen. (a) Powerblot analysis of MIA/CD-RAP negative Hmb2-cells showed strong downregulation of p54
nrb
arrow indicates p54
nrb.( b) Relative expression levels of p54
nrb was signiﬁcantly decreased in adult murine cartilage of ear and sternum of MIA /  mice measured by qRT-
PCR. Data are represented as means±S.D., after normalization to WT tissue. (c) P54
nrb immunohistostaining of rips of 15.5-days old mouse embryos. Protein expression
was reduced in MIA /  mice. P54
nrb expression was reduced during redifferentiation of dedifferentiated chondrocytes from MIA/CD-RAP deﬁcient mice. (d) Relative mRNA
expression levels of p54
nrb were decreased in redifferentiated chondrocytes measured by qRT-PCR. Redifferentiation was induced by spheroid formation and treatment with
TGF-b3. Data are represented as means±S.D., after normalization to untreated cells. (ns, not signiﬁcant; *Po0.05; **Po0.01)
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Cell Death and DiseaseDiscussion
It is known that MIA/CD-RAP is strongly induced at the
beginning of chondrogenesis during fetal development
3 and
expressed throughout cartilage development.
5 As MIA/CD-RAP
was revealed to be a speciﬁc marker for chondrocytic
differentiation,
6 there is evidence for its role in cartilage
development. Since the molecular function of MIA/CD-RAP
in cartilage and bone formation was not analyzed in detail
so far, we aimed to understand the role of MIA/CD-RAP
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Figure 4 Enhancedproliferation anddelayeddifferentiationin MIA /  mMSC is mediatedthrough p54
nrb.( a) Western blot and mRNAexpressionanalysis by qRT-PCR
of murine mesenchymal stem cells transfected with siRNA speciﬁc for p54
nrb. On protein and mRNA levels, p54
nrb was successfully downregulated compared with si control
transfected cells. The data are represented as means±S.D., after normalization to the control siRNA. (b) The transcriptional activity of the Col2a1 promoter (I) measured by
reporter gene assay and Col2 mRNA expression levels (II) are reduced in WT cells transfected with siRNA against p54
nrb. MIA /  MSC showed no alteration in Col2a1
promoter activity (III) and Col2 mRNA expression (IV) after treatment with p54
nrb siRNA. Simultaneous reexpression of hMIA and silencing of p54
nrb led to decreased Col2a1
promoter activity. Cells transfected with control plasmid showed no signiﬁcant difference in Col2a1 promoter activity (V). Differentiation was induced by TGF-b3. Data are
represented as means±S.D., after normalization to pGL2basic transfected cells. (c) Overexpression of p54
nrb in MIA /  mMSC led to a signiﬁcant decrease in Cyclin D2
mRNA expression (I). Relative expression of Cyclin D2 was increased through knockdown of p54
nrb in WT mMSC (II). Data are represented as means±S.D., after
normalization to control. (d) Relative proliferation for 8 days of MIA /  and WT mesenchymal stem cells. Differentiation was induced by TGF-b3. MIA /  cells in which
hp54
nrb was overexpressed showed signiﬁcant reduction in proliferation when treated with TGF-b3 (I). WT cells in which p54
nrb expression was knocked down by siRNA
showednoalterationinrelativeproliferation(II).Thedataarerepresentedasmeans±S.D.,afternormalizationtountreatedcells.SimultaneousreexpressionofMIA/CD-RAP
and knockdown of p54
nrb in MIA /  mMSC indicated no difference in relative proliferation, whereas reexpression of hMIA alone led to reduction of proliferation (III).
Differentiation was induced by TGF-b3. The data are represented as means±S.D., after normalization to untreated cells. (ns, not signiﬁcant; *Po0.05; **Po0.01;
***Po0.001)
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Cell Death and Diseasein cartilage development. Previously, we could show that
MIA/CD-RAP can modulate BMP2-induced osteogenic
differentiation towards chondrogenic differentiation.
19 In more
detail, we could demonstrate inhibition of ERK signalling by
MIA/CD-RAP, mediated through binding of MIA/CD-RAP to
integrin alpha 5 and inhibiting its activity. Active ERK
signalling is known to block chondrogenic differentiation, so
MIA/CD-RAP stabilizes cartilage differentiation and inhibits
differentiation into bone.
11 Additionally, MIA/CD-RAP-deﬁ-
cient mice showed a disordered spatial arrangement of
chondrocytes and an enlarged layer of calciﬁed cartilage in
articular cartilage indicating changes of cartilage maturation
possibly involving an altered temporal pattern of prolifera-
tion.
11 These results further support the hypothesis
of MIA/CD-RAP being an important element in cartilage
development.
As MIA /  mice are viable, develop normally and
histological examination of cartilage by means of light
microscopy revealed no major abnormalities,
10 we focused
ﬁrst on in vivo models, in which cartilage formation and
regeneration could be studied. Here, we present in vivo
models for fracture healing and osteoarthritis, which clearly
showed enhanced chondrocytic regenerative capacity under
MIA/CD-RAP deﬁciency. In a model for osteoarthritis,
proliferating chondrocytes could be determined for the ﬁrst
time because of loss of MIA/CD-RAP clearly illustrating the
highly regenerative potential in mature cartilage. Conse-
quently, proliferating chondrocytes together with their
increased matrix production not only counteract development
of lesions in MIA /  mice as seen at day 21 of OA compared
with WT but also promotes enhanced regeneration at day 42,
although OA proceeds in WT. The score of MIA /  mice 42
days after OA induction decreased to the level of the control
group, which leaves no doubt to the enhanced regenerative
capacity by loss of MIA/CD-RAP. In fracture healing we
revealed that cartilage formation proceeds faster in MIA / 
mice compared with WT through forced proliferation of
collagen type II-positive undifferentiated chondrocytes under
MIA/CD-RAP deﬁciency. However, as also seen in the adult
MIA-deﬁcient mice, the overall amount of cartilage did not
differ hinting to secondary regulation counteracting lack of
MIA/CD-RAP during development.
In cell-culture experiments we revealed that regeneration is
enabled by the lack of MIA/CD-RAP through enhanced
proliferation of mesenchymal stem cells and delayed differ-
entiation during chondrogenesis. Enhanced proliferation is
mediated by cell-cycle regulation through upregulation of
Cyclin D2 expression promoting progression from G1 to S
phase of cell cycle. Loss of MIA/CD-RAP decelerated
differentiation exempliﬁed by reduced Col2a1 promoter
activity and by a delay in aggrecan mRNA expression (data
not shown).
In this study, we could identify p54
nrb as a mediator of MIA/
CD-RAP in this regulation. Recent studies revealed that
p54
nrb physically interacts with Sox9 and enhances Sox9-
dependent transcriptional activation of the Col2a1 promoter,
which leads to progression of chondrogenesis.
17 We were
able to show that MIA/CD-RAP modulates chondrogenesis by
initiating a stop of proliferation and inducing differentiation in
both cases through p54
nrb. P54
nrb mediates differentiation
through enhanced Sox9-dependent Col2a1 expression,
whereas inhibition of proliferation is mediated by negative
cell cycle regulation through Cyclin D2. The original ﬁndings
that MIA/CD-RAP expression is regulated by the transcription
factor Sox9
20 and AP-2
21 (Figure 5b) has to be modiﬁed in a
way that MIA/CD-RAP can also act upstream of Sox9 to
promote differentiation (Figure 5c). It is known that the MIA/
CD-RAP promoter contains a SOX consensus sequence to
which the Sox9 protein is able to bind, leading to a dose-
dependent increased activity of the promoter.
20 MIA/CD-RAP
is speciﬁcally expressed during chondrogenesis
5 and
generally considered to be characteristic of cartilage.
3
Surprisingly, Sox9 is not able to induce endogenous
CD-RAP expression in mesenchymal cells in contrast to
chondrocytes, which implies that other factors are involved in
chondrogenesis,
20toinducethechondrocytephenotype.This
ﬁnding matches with our results, as we could show that in
mesenchymal stem cells MIA/CD-RAP acts upstream from
Sox9 and promotes chondrogenesis in early stages through
p54
nrb. We could reveal no regulation of p54
nrb by MIA/CD-
RAP through ERK-signalling and have to further analyse the
regulation of p54
nrb through MIA/CD-RAP.
In summary, our data indicate that MIA/CD-RAP is required
for differentiation in cartilage upstream of the transcription
b
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Figure 5 (a) No regulation of p54
nrb through ERK signaling. Inhibition of ERK signaling using MEK1/2 speciﬁc inhibitors UO126 and PD98059 in WT mMSC led to no
regulation of p54
nrb expression, neither on mRNA nor on protein level. The data are represented as means±S.D., after normalization to DMSO-treated cells. (b and c)
Schematicdrawing of MIA/CD-RAP regulation in cartilage development. MIA/CD-RAP mediatesdifferentiation of mesenchymalstem cells throughregulation of collagen type
II expression through activation of p54
nrb, arrows represent activation. Bold arrows indicate differentiation progress. (ns, not signiﬁcant)
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Cell Death and Diseasefactor Sox9. It regulates signalling processes during
differentiation through p54
nrb. Most impressively, the lack of
MIA/CD-RAP expression results in cartilage repair and
enhanced proliferation of cartilage precursor cells. We feel
that this investigation of MIA/CD-RAP in cartilage will help to
understand its molecular impact and will give new insight in
the approach of developing therapies for cartilage regenera-
tion in arthritis.
Materials and Methods
Mice. Transgenic animals were generated as described previously.
10 C57Bl/6
control and MIA/CD-RAP-knockout mice were bred under speciﬁed pathogen-free
conditions at 261C, 70% relative humidity, and a 12-h light/12-h dark cycle at the
University of Regensburg. They were fed with a breeding/maintenance diet
(Altromin GmbH, Lage, Germany) and water ad libitum. The mice were randomly
housed in polypropylene cages with sawdust bedding. The cages were sanitised
twice weekly. Embryos were harvested on day 15.5 days post-coitum (dpc),
whereasday0.5wasonthedayofdetectionofthevaginalplug.Animalcareandall
experimental procedures were carried out in accordance with guidelines of the
German law governing animal care. Experiments were approved by the Ethics
Committee for Animal Research of the Bavarian government.
Animal studies. Cartilage formation and regeneration was determined in
models for osteoarthritis and fracture healing in vivo. Osteoarthritis in 6-week old
mice (MIA /  and WT) was induced by detaching the medial meniscotibial
ligament from the tibia plateau. Brieﬂy, under general anesthesia using
intraperitoneal injections of Ketamin (90mgkg
 1) and Xylazin (10mg/kg), the
bilateral hind limbs were prepared for aseptic surgery. The knee joint was exposed
following a medial incision without transection of the patellar ligament. Then, the
medial meniscus was removed using a surgical microscope. After replacement of
the extensor muscle, the medial incision was sutured, and the skin was closed.
During the procedure, close attention was paid not to injure the articular cartilage.
The mice were killed at day 10, and 3 and 6 weeks after operation, and the knees
were dissected, ﬁxed in 4% paraformaldehyd in phosphate-buffered saline (PBS),
decalciﬁed in 20% ethylene diamine tetraacetic acid (EDTA, Sigma, Taufkirchen,
Germany), and parafﬁn embedded. Sections (5mm) were cut, stained with HE, and
the progress of OA was scored by stage and grade using the scoring system
proposed by Pritzker et al.
22 To analyse proliferating cells, PCNA staining was
performed as described below.
For fracture healing, 6–8-weeks old mice (MIA /  and WT) of both genders
were used. After anesthesia with an intraperitoneal injection of Ketamin
(90mgkg
 1) and Xylazin (10mgkg
 1) standardized non-stable fractures were
produced distal to the crest of the tibia in accordance with the German animal
protective law (Grant no. 54-2531.1-12/05). The mice were killed by
CO2-intoxication at days 5, 7, 9 and 11 after fracture. The fractured tibia and the
collateral, unfractured control tibiae were dissected, ﬁxed in 4% freshly prepared
paraformaldehyde in PBS, and parafﬁn embedded for immunohistological analysis.
Sections (4mm) were cut through the long axis of each tibia in a sagittal plane and
adjacent sections were stained with Weigert’s hematoxylin/alcian blue/sirius red
(Sigma) or processed for immunohistochemistry. To evaluate the expression and
localization of collagen type II, collagen type X and PCNA in the callus tissue during
fracture healing, the following antibodies were used: mouse anti collagen type II
(Developmental studies hybridoma bank, Iowa, USA), mouse anti collagen type X
(Quartett, Berlin, Germany), and mouse anti PCNA (Dako, Hamburg, Germany).
The deparafﬁnized and rehydrated serial sections were heat treated with 0.1M
citratebuffer,pH6.0incaseofPCNAandpreincubatedwithproteaseXXIV(Sigma;
0.05% in PBS for 10min at 371C) and testicular hyaluronidase (Sigma; 0.1% in
acetatebuffer,pH6.0,for90minat371C)incaseofcollagentypeIIandX.Afterthe
pre-treatment,thesectionswerewashedseveraltimesinPBSandbrieﬂyincubated
with 0.3% H2O2 for 10min at room temperature to block endogenous peroxidase
activity. For the staining, a commercial biotinylation kit was used (ARK, Dako). The
sections were counterstained in Weigert’s hematoxylin, dehydrated and mounted.
Sections incubated without the primary antibody served as a negative control. No
sections showed any staining in such control experiments (data not shown). The
evaluationof thestainingwasperformedsemiquantitativelybylight microscopy.For
histomorphometry, the callus proximally of the fracture line along the extensor side
of the tibia was deﬁned as the region of interest. To determine the cartilage and
bone content in this region of interest, sagittal sections stained with Weiger’s
hematoxylin/alcian blue/sirius red from all time points and tibial growth plates from
fractured and unfractured legs were photographed using a digital camera (DS-5M,
Nikon, Du ¨sseldorf, Germany). The images were imported into PhotoShop, and the
software was used to select the areas of cartilage and bone in each callus. For the
quantiﬁcation of the selected pixels UTHSCSA ImageTool was used. The image
software Eclipse-Net (Nikon) was used for the following histomorphometrical
measurements: determination of the diameter of hypertrophic chondrocytes, and
the quantiﬁcation of hypertrophic chondrocytes per area.
Cell isolation and cell culture of primary murine MSCs and
chondrocytes. MSCs were isolated from bone marrow of tibia and femur of
6–8-weeksoldmiceandgrowninvitroinDulbeccomodiﬁedEaglemedium(DMEM)
(PAA, Pasching, Austria), consisting of high glucose (Sigma), 20% fetal calf serum
(FCS; PAN Biotech GmbH, Aidenbach, Germany), MEM vitamins (Invitrogen,
Karlsruhe, Germany), penicillin (100U per ml), streptomycin (10mgml
 1) (both
Sigma), and Amphotericin B (2.5mgml
 1) (PAN Biotech GmbH) and were
incubated in humidiﬁed atmosphere containing 5% CO2 at 371C. Medium was
replaced 24h after isolation to select for plastic-adherent cells and every 3 days
thereafter. Conﬂuent cultures (B3 10
4 cells per cm
2) were passaged at 1:2.
Cells were washed with PBS (pH 7.4, PAA) and were detached from culture ﬂasks
by incubating for 3min at 371C in a PBS solution supplemented with 0.05% trypsin
and 0.02% ethylenediaminetetraacetic acid (Invitrogen). All experiments were
performed at passage three to six.
MSC were treated with DMSO, UO126 and PD098059, respectively, (all
CALBIOCHEM, Nottingham, UK) and incubated for 48h followed by RNA and
protein isolation.
BrdU/Hoe-quenching technique. For BrdU/Hoechst33258 (Hoe)-
quenching measurements, 5 10
5 cells were seeded on day 0 into T25 culture
ﬂasks (Corning Inc., Corning, NY, USA) and were incubated for 7 days. On day 3
and 5 after cell seeding, medium was changed and cells were treated with 120mM
BrdU (Sigma). To minimize potential disturbance in the nucleotide pathway due to
BrdU treatment, medium was also supplemented with half-equimolar
20-deoxycytidine (Sigma).
23 For BrdU/Hoe-quenching cell staining, cells were
harvested on day 7 through trypsination and washed twice with ice cold DNA-
washing buffer (100mM Tris-HCl pH 7.4, 154mM NaCl, 1mM CaCl2, 0.5mM
MgCl2,0.2%bovineserumalbumin(BSA))(allMerck,Darmstadt,Germany).Atotal
of 5 10
5 cells were resuspended in 0.5ml DNA-staining buffer (100mM Tris-HCl,
pH 7.4, 154mM NaCl, 1mM CaCl2, 0.5mM MgCl2, 0.2% BSA (all Merck), 0.1%
IGEPAL CA-630 (Nonylphenyl-polyethylenglycol) (Sigma) supplemented with
40mgml
 1 (2–4U per ml) RNase (Roche Applied Science, Mannheim, Germany)
and 1.2mgml
 1 Hoechst 33258 (Sigma) and incubated for 15min at 371C.
24,25
Cellular DNA content was stained with PI (1.5mgml
 1) (Sigma) for 15min on ice.
Flow cytometry instrumentation and data analysis. An LSR-I three
laser ﬂow cytometer(Becton DickinsonBiosciences,San Jose,CA, USA) was used
for BrdU/Hoe-quenching measurements. A 325nm ultraviolet laser line was used
for Hoe excitation. PI ﬂuorescence was excited with an air-cooled 488nm argon
laser. Fluorescence emission was detected through 425/44 band-pass and 630/22
band-pass ﬁlter optic, respectively. Sample measurements and data analysis were
performedwith Diva software6.1.1 (BectonDickinsonBiosciences).Cell debrisand
aggregates were excluded from analysis using pulse processing (DNA width signal
against DNA area signal). By drawing regions around the initial G0 cell fraction
(Figure3a),weidentiﬁedcellsthatremainedBrdUnegativewithinaperiodof96hof
BrdU incubation time, indicating quiescent cells. Quantiﬁcation of cell cycle
distribution was performed with FlowJo software (Tree Star Inc., Ashland,
OR, USA).
siRNAknockdown. MSCs were transfected with gene-speciﬁcsiRNA against
p54
nrb purchased from Qiagen (Hilden, Germany) or MIA/CD-RAP purchased from
Sigma. A negative scramble siRNA (Qiagen) was used as a control. Transfection
was performed according to the manufacturer’s speciﬁcation using Lipofectamine
2000reagent(Invitrogen).At2daysaftertransfection,cellswereharvestedforRNA
isolation and plated for proliferation assays as described elsewhere. For Luciferase
assay cells were used after 1 day of transfection as described below.
NucleofectionwithplasmidDNA. NucleofectionofmMSCwasperformed
using the Human MSC Nucleofector Kit from Lonza (Basel, Switzerland).
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Cell Death and DiseaseManufacturer’sinstructionshavebeenslightlymodiﬁed.Atotalof1 10
6cellswere
resuspended in 100ml complete nucleofector solution. The pCMX-PL1-human
MIA/CD-RAP plasmid or the pCMV-SPORT6-hp54
nrb plasmid (ImaGenes, Berlin,
Germany, BC028299) both under the regulation of a cytomegalovirus (CMV)
enhancer/promoter element, was then added (2mg per transfection sample) to
the cell suspension. As a control, cells received the empty expression construct
pCMX–PL1. The cell/DNA mixtures were transferred into certiﬁed cuvettes (Lonza)
and transfected by using program C-17. Following the electroporation, the cells
were incubated in culture medium pre-heated to 371C for 2 days, and then seeded
for proliferation assays, luciferase assay and RNA harvest as described elsewhere.
Differentiation. For analysis of chondrogenesis murine MSC differentiation
and chondrocyte redifferentiation was performed as 3D pellets. The 3D pellet
culture facilitates the in vitro differentiation of mesenchymal stem cells into
chondrocytes.
26 For this, 2.5 10
5 cells were seeded into 15ml polypropylene
tubes (Greiner Bio-One GmbH, Frickenhausen, Germany) and pelleted at 150 r.c.f.
for 2min. Cells were cultured for the indicated period as 3D pellets in induction
medium including DMEM (PAA), high glucose (Sigma), 20% FCS (PAN Biotech
GmbH), MEM Vitamins (Invitrogen), penicillin (100U/ml), streptomycin (10mg/ml)
(both Sigma), Amphotericin B (2.5mg/ml) (PAN Biotech GmbH), 0.1mM
dexamethasone, 1mM sodium pyruvate, 0.17mM ascorbic acid-2-phosphate,
0.35mM proline (all Sigma), insulin (5mg/ml), transferring (5mg), selenious acid
(5ng) (ITS Premix, Becton Dickinson, Minneapolis, MN, USA) and 10ng/ml human
TGF-b3 (R&D Systems). The medium was changed every second day. All groups
were done in triplicate. Each experiment was repeated three times. RNA was
harvested at days 2, 4and 6 in caseof mMSCandeveryday between1 and 6 days
in case of chondrocytes.
RNA isolation and RT-PCR. Total RNA from cell culture, tissue (sternum
andearof6–8-weeksoldmice)or3Dpelletswasisolatedusinge.Z.N.A.MicroElute
Total RNA Kit (peqlab Biotechnologie GmbH, Erlangen, Germany) as described by
the manufacturers. Each three mMSC pellets were pooled and total RNA was
isolatedafterindicateddaysofculture.RNAconcentrationandpuritywasmeasured
by NanoDrop (peqlab Biotechnologie GmbH). cDNA was generated by RT. The RT
reaction was performed in 20ml reaction volume containing 500ng of total RNA,
4mlo f5  ﬁrst-strand buffer, 2ml of 0.1M DTT (both Invitrogen),1mlo fd N 6 primer
(10mM) (Roche, Mannheim, Germany), 1ml of dNTPs (10mM) (Amersham
pharmacia biotech, Pittsburgh, PA, USA) and DEPC water. The reaction mix was
incubated for 10min at 701C. Then 1ml of Superscript II reverse transcriptase
(Invitrogen) was added, and RNA was transcribed for 1h at 371C. Subsequently,
reversetranscriptasewasinactivatedat701Cfor10min,andRNAwasdegradedby
digestion with 1ml RNase A (10mg/ml) (Roche) at 371C for 30min. The quality of
cDNA was controlled and normalized by qRT-PCR ampliﬁcation of the house
keeping gene b-actin.
Quantitative real-time PCR. Quantitative RT-PCR was performed with a
Lightcycler (Roche). A volume of 2ml cDNA template, 0.5ml of forward and reverse
primer (20mM) for each collagen type II, p54
nrb or Cyclin D2 and 10ml of SYBR
Premix Ex Taq (TaKaRa, Otsu, Japan) were combined to a total volume of 20ml.
PCR primers were obtained from Sigma.
The PCR program used was 30s, 951C (initial denaturation); 201Cs
 1
temperature transition rate upto 951C for 3s; 10s 581C; 8s 721C, 851C acquisition
mode single, repeated for 40 times (ampliﬁcation). Annealing and acquisition
temperatures were optimized for each primer set. The PCR product was evaluated
bymelting-curveanalysisaccordingtothemanufacturer’sinstructions andchecking
the PCR products on 1.8% agarose gels. Each analysis was performed at least
in triplicate. The expression ratios of the analyzed genes were calculated using an
internal control standardcurveof b-actin levels.Primersused for PCRare shown in
Table 1.
Luciferase assay. For transient transfections, 2 10
5 mMSC were seeded
into each well of a six-well plate and transfected with 0.5mg plasmid DNA using the
Lipofectamine plus method (Gibco, Karlsruhe, Germany) according to the
manufacturer’s instruction. Cells were cultured in induction medium (see above)
including 10ng/ml human TGF-b3 (R&D Systems) to induce chondrogenic
differentiation.Thecells were lysed 24h aftertransfectionand theluciferase activity
in the lysate was quantiﬁed by a luminometric assay (Promega Corp., Madison, WI,
USA). Transfection efﬁciency was normalized according to renilla luciferase activity
by cotransfecting 0.1mg of the plasmid pRL-TK (Promega, Mannheim, Germany).
All transfections were repeated at least three times. For transient transfection the
COL2A1 LUC reporter construct
27 kindly provided by Linda J. Sandell was used.
Cell proliferation kit II (XTT). Cells were seeded as monolayer cultures in
100mlcultivationmedium(seeabove)withoutphenolredina96-wellplate(Corning
Inc.) at a density of 1 10
4 and 2 10
4 cells per well and incubated in humidiﬁed
atmospherecontaining5% CO2 at 371C for theindicatedtimeperiods.Experiments
wereperformedintriplicates.Mediumwaschangedafter4days.Differentiationwas
inducedby 10ng/ml TGF-b3 (R&D Systems). After2, 4, 6 and 8 daysof incubation,
50ml of XTT labeling and electron-coupling reagent (Roche) was added to the
respective well, and plates were incubated at 371C. Absorbance was measured
after 2 and 4h of incubation at 450nm against a reference wavelength at 650nm
usingamicroplatereader(MolecularDevices,Sunnyvale,CA,USA,Emaxprecision
microplate reader).
Westernblotting. Cellswerelysedin75mlRIPAbuffer(Roche)andincubated
for 15min at 41C. Insoluble fragments were removed by centrifugation at 16100
r.c.f. for 10min at 41C and the supernatant was stored at  201C. Protein
concentrations were determined using the BCA protein assay reagent (Pierce,
Rockford, IL, USA). In all, 75mg (Cyclin D2) and 50mg (p54
nrb) protein per lane
were denatured at 701C for 10min after addition of Roti-load-buffer (Roth,
Karlsruhe, Germany) and subsequently separated on 12–15% SDS-PAGE gels.
After blotting onto PVDF-membranes (Bio-Rad, Richmond, CA, USA) and blocking
for 1h with 3% BSA/PBS (p54
nrb) and 5% milk/TBST (0.1%) (Cyclin D2),
respectively, membranes were incubated overnight at 41C with one of the following
antibodies:anti-p54
nrb(BDBiosciences,Bedford,MA,USA),anti-CyclinD2(Abcam,
Cambridge, UK), and anti b-actin (Sigma, Deisenhofen, Germany). After three
washing steps with PBS and TBST (0.1%), respectively, the membrane was
incubated for 1h with an alkaline phosphate-coupled secondary anti-mouse IgG
antibody (Chemicon, Hofheim, Germany) and then washed again. Finally,
immunoreactions were visualized by BCIP/NBT (Sigma) staining.
Immunohistochemistry. Parafﬁn-embedded preparations of 15.5-days old
WT and MIA /  embryos were screened for p54
nrb protein expression by
immunohistochemistry. Samples were deparafﬁnised, rehydrated, heat treated with
Tris–EDTA andsubsequentlyincubatedwith primarymonoclonal mouse anti p54
nrb
antibody (1:10000; BD Biosciences) for 30min at room temperature. The
secondaryantibodyEnvision(Dako)was incubatedfor 30min at room temperature.
Antibody binding was visualized using DAB-Chromogen (Dako). Finally, the tissues
were counterstained by hematoxylin. The evaluation of the staining was performed
semi quantitatively by light microscopy.
Table 1 Primer used for quantitative real-time PCR
Gene Sequence (50–30) Product length NCBI reference sequence
Col2a1 for CTA CTG GAG TGA CTG GTC CTA AGG 262bp NM001113515
Col2a1 rev GGA CCA TCA TCT CCA GGT TCT CC
p54nrb for GGC TTT GGC TTT ATT CGC TTG 356bp NM023144
p54nrb rev TCC ATA GGC TCC ACA GTC AC
Ccnd2 for AAG GAG GTA AGG GAA GCA CTC 228bp NM009829
Ccnd2 rev GAA ATA GGA ACA CTG CGG GAG
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Cell Death and DiseasePowerBlot. We used a PowerBlot Western Array screening system conducted
by BD Biosciences to reveal regulated proteins in HMB2 cell clones stable
transfected with a MIA/CD-RAP-antisense expression plasmid published by Tatzel
et al.
16 Experiments were conducted in triplicates.
Plasmids. The expression vectors used for re-expression were pCMX-PL1-
human MIA/CD-RAP and pCMV-SPORT6-hp54
nrb containing full-length cds cloned
by ImaGenes. The sequence of the hp54
nrb construct was conﬁrmed by DNA
sequencing performed at Entelechon, Regensburg, Germany.
Statistical analysis. The mean and S.D. values were calculated from
independent experiments, and the graphs were constructed with the GraphPad
Prism software. Statistical signiﬁcance between two groups was determined by
using the Student’s t-test. Software used was GraphPad Prism 4. Statistical
signiﬁcance was analyzed on data from at least three independent experiments.
A P-value o0.05 was considered statistically signiﬁcant (NS, not signiﬁcant;
*Po0.05; **Po0.01; ***Po0.001).
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